RSS   Newsletter   Contact   Advertise with us
Post Online Media

Agendia appoints Patrick J. Balthrop Sr. as non-executive chairman

AgendiaAgendia, a personalized medicine and molecular cancer diagnostics company, announced the appointment of Patrick J. Balthrop Sr. as non-executive chairman.
Article continues below

READ MORE Agendia names Mark R. Straley as new CEO

Mr. Balthrop is currently a Director at Oxford Immunotec Global, Personalis, Inc. and Concert Genetics.

Mr. Balthrop is an advisor to Water Street Healthcare Partners and the Founding Principal of Apalachee Ventures, an investment and advisory firm.

He previously held positions of CEO, President and Director at Luminex, and President at Fisher Healthcare (then Fisher Scientific).

Mr. Balthrop has also held a number of positions within Abbott Laboratories, including President of Abbott Vascular and Corporate VP, Worldwide Commercial Operations.

He has an MBA from the Kellogg School of Management, Northwestern University and a BS in Biology from Spring Hill College.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy